NCT04722601 2024-05-16A Dose-Finding and Efficacy Study of Venetoclax, CC-486, and Obinutuzumab in Follicular LymphomaUniversity of ChicagoPhase 1/2 Terminated2 enrolled 7 charts
NCT01908387 2015-07-28Phase 1 Study of CC-486 in Japanese Subjects With Hematological NeoplasmsCelgenePhase 1 Terminated2 enrolled